Pacific Biosciences of California, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↓-37.8% -$476M
$784M
Current Assets↓-24.3% -$121M
$375M
Cash & Equivalents↑+15.1% +$8M
$64M
ST Investments↓-35.5% -$119M
$216M
Receivables↑+28.8% +$8M
$35M
Inventory↓-16.1% -$9M
$49M
Net PPE↓-20.8% -$6M
$24M
Goodwill↑+0.0% +$0
$318M
Intangibles↓-96.1% -$374M
$15M
Total Liabilities↑+3.3% +$25M
$779M
Current Liabilities↑+9.9% +$7M
$73M
Account Payables↑+25.2% +$4M
$21M
Long-Term Debt
—
Short-Term Debt
$0
Stockholders Equity↓-98.9% -$501M
$5M
Retained Earnings↓-25.4% -$546M
$-2.70B
Operating Lease ROU Asset↑+159.1% +$26M
$42M
Operating Lease Liability↑+282.5% +$42M
$57M
Gross PP&E↑+3.7% +$4M
$117M
Accumulated Depreciation↑+12.8% +$11M
$92M
Inventory Raw Materials↓-14.6% -$7M
$39M
Inventory WIP↑+22.0% +$5M
$27M
Inventory Finished Goods↑+11.6% +$2M
$16M
Debt Due Y1
—
Debt Due Y2
—
Debt Due Y3
—
Debt Due Y4
—
Debt Due Y5
—
Debt Due >Y5
—
Total Debt Carrying Amount
—
Contract Liability↑+0.5% +$101K
$20M
Contract Liability (Current)↑+14.9% +$2M
$16M
Contract Liability (Noncurrent)↓-33.4% -$2M
$4M
Remaining Performance Obligation↓-16.0% -$9M
$49M